DUBLIN, June 17, 2016 /PRNewswire/ --
Research and Markets has announced the addition of the "Cell Expansion Market by Product (Reagent, Media, Flow Cytometer, Centrifuge, Bioreactor), Cell Type (Human, Animal), Application (Regenerative Medicine & Stem Cell Research, Cancer), End user (Research Institute, Cell Bank)-Global Forecasts to 202" report to their offering.
The global cell expansion market consists of various products used for the mass production of cells. The growth of this market is driven by several factors such as increasing government funding for research, high prevalence of chronic diseases, rising company investments for the development of cell-based products, and growing number of GMP-certified production facilities. High potential growth in emerging markets has opened an array of opportunities for the market. However, the high cost of cell-based research and ethical concerns are hampering the growth of the global market.
The cell expansion market is expected to reach USD 18.76 Billion by 2021 from USD 8.34 Billion in 2016 at a CAGR of 17.6%. This market is segmented based on product, cell type, application, end user, and region.
Based on cell type, the cell expansion market is segmented into human cells and animal cells. Human cells include stem cells and differentiated cells. Stem cells segment is further classified into adult stem cells, embryonic stem cells, and induced pluripotent stem cells. Adult stem cells are expected to grow at the highest rate due to increasing research investments by public and private organizations in stem cells.
On the basis of application, the cell expansion market is segmented into regenerative medicine and stem cell research, cancer and cell-based research, and others. Regenerative medicine and stem cell research is expected to account for largest share in 2016. This is attributed to the increasing investments by companies for the development of cell-based therapies.
- Beckman Coulter, Inc. (Subsidiary of Danaher Corporation)
- Becton, Dickinson and Company
- Corning, Inc.
- GE Healthcare (A Wholly Owned Subsidiary of General Electric Company)
- Lonza Group Ltd.
- Merck KGAA
- Miltenyi Biotec
- Stemcell Technologies
- Terumo BCT, Inc. (A Subsidiary of Terumo Corporation)
- Thermo Fisher Scientific, Inc.
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Cell Expansion Market, By Product
7 Cell Expansion Market, By Cell Type
8 Cell Expansion Market, By Application
9 Cell Expansion Market, By End User
10 Cell Expansion Market, By Region
11 Competitive Landscape
12 Company Profiles
For more information visit http://www.researchandmarkets.com/research/xg6jlm/cell_expansion
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/research-and-markets---global-cell-expansion-market-value-of-usd-1876-billion-by-2021---trends-technologies--opportunities-report-2016-2021---key-vendors-merck-miltenyi-biotec-ge-healthcare-300286507.html
SOURCE Research and Markets